11.06.2007 - 11:59pm ET

(CSRwire) NEW YORK, NY - November 6th - Diane Keaton, Andie MacDowell, President of L'Oréal Paris Carol J. Hamilton and Harper's Bazaar Editor-in-Chief Glenda Bailey will co-host "A Night of Hope" to benefit The Ovarian Cancer Research Fund (OCRF) on Wednesday, November 7th at Murano from 6:30 – 9:30 PM in Los Angeles, CA. They will be joined by other L'Oréal spokespeople including Eva Longoria, Kerry Washington, and Dayle Haddon.

The evening will include a cocktail reception and luxury silent auction, which will feature exceptional photography and fashions and accessories from designers including Chanel, Louis Vuitton, Donna Karan, Bulgari and De Beers.

"A Night of Hope" is hosted by L'Oréal Paris and all proceeds raised at the event will be donated to OCRF's research programs. President of L'Oréal Paris, Carol J. Hamilton says, "This year marks the tenth anniversary of L'Oréal Paris' support of The Ovarian Cancer Research Fund. I am proud of the fact that L'Oréal is the largest corporate fundraiser in this critical fight against ovarian cancer. Since 1997, we have helped to raise over $13 million to fund life-saving research and to promote awareness building programs to help empower women to make educated choices about their health and well-being."

Additionally, L'Oréal has created programs to promote ovarian cancer awareness, which include the first-ever public service announcements for ovarian cancer featuring L'Oréal spokespeople Andie MacDowell and Milla Jovovich. L'Oréal has also created the signature "Color of Hope" cosmetics and jewelry collections that raise funds for OCRF. This year L'Oréal has added a sterling silver pendant and earrings to the jewelry collection. All of the jewelry items are available for purchase online at www.lorealcolorofhope.com. A special diamond Color of Hope necklace has been created to commemorate this star-studded event.

"Awareness is a key element in winning the fight against ovarian cancer. There is currently no effective, easy to use method of early detection for ovarian cancer and as a result, many of the cases are diagnosed too late. In addition to raising much needed funds for research programs, L'Oréal has been extremely instrumental in spreading the message that every woman should have knowledge of this disease and its symptoms," explains Elizabeth Howard, CEO of OCRF.

For more information about "A Night of Hope", please contact Jennifer Doll at London Misher Public Relations at 212.759.2800 or jdoll@londonmisherpr.com.

ABOUT L'ORÉAL PARIS

L'Oréal Paris is dedicated to women around the world and the company has been inspired to give back and make a difference in their lives. In 1997, L'Oréal Paris made a long-term commitment to The Ovarian Cancer Research Fund (OCRF), which continues to build. To date, L'Oréal Paris has helped raise over $13 million dollars on behalf of OCRF with fundraising efforts such as the L'Oréal Legends Gala and L'Oréal's annual "Color of Hope" bracelet and cosmetic collection.

The L'Oréal Paris Brand Division of L'Oréal USA, Inc. is a total beauty care company that combines the latest in technology with the highest in quality for the ultimate in luxury beauty at mass. The L'Oréal Paris product family includes Preference, Excellence, Natural Match, Feria, and Couleur Experte haircolors; VIVE Pro, Studio Line, and L'Oréal Kids hair care; Dermo-Expertise skin care, including Skin Genesis; Advanced Revitalift, Wrinkle De-Crease, Age Perfect, Men's Expert, Sublime Slim and Sublime Bronze; and L'Oréal Paris Cosmetics, including Colour Riche Lipcolours, Infallible Never Fail Lipcolour, True Match Makeup, Wear Infinite Eyeshadows, Voluminous, Double Extend, Telescopic, and Volume Shocking mascaras, among many others, and the HIP High Intensity Pigments line.

ABOUT THE OVARIAN CANCER RESEARCH FUND

The Ovarian Cancer Research Fund (OCRF) is the leading independent, non-profit organization in the United States dedicated to advancing research, raising awareness and finding a cure for ovarian cancer. Ovarian cancer takes the lives of over 15,000 women in the United States each year, with over 20,000 new cases being diagnosed annually. There is currently no method of early detection, leading to late diagnosis in 75 percent of all cases. OCRF is committed to funding the best and the brightest of scientific investigators whose work focuses on new tools for detection and better treatment options. To date, OCRF has funded researchers at 40 leading cancer centers nationwide. For more information, go to www.ocrf.org

For more information please contact: